ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 702117 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 702117; 2) Community: the network communities that were significantly associated with the response to NSC 702117; 3) Molecule: the relationships between components within communities and NSC 702117; 4) MDR: the compounds that were significantly associated with the NSC 702117.

NSC Compound Enrichment Correlation
NSC 698057 Null 0.0312262198176283 0.52810072
NSC 23925 Null 0.0352383000003056 0.40196594
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0352383000003056 0.16752155
NSC 281818 Ethanol, 2,2'-[[3-methyl-4-[[[4-[2-(4-propoxyphenyl]-4-thiazolyl]phenyl]imino]methyl]phenyl]imino]bis-, dimethanesulfonate (ester) 0.0352383000003056 -0.11198057
NSC 303861 L-Cysteine analog 0.0352383000003056 0.4815712
NSC 339137 PHYSALOLACTONE 0.0352383000003056 0.2771668
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0352383000003056 0.23747037
NSC 359239 Antibiotic X-14766A 0.0352383000003056 0.11137058
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0352383000003056 0.02348105
NSC 371777 Null 0.0352383000003056 0.064247172
Total:124  Current:92    [First] [Prev] [Next] [Last]